183 related articles for article (PubMed ID: 21555324)
1. Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink).
Brachmann J; Böhm M; Rybak K; Klein G; Butter C; Klemm H; Schomburg R; Siebermair J; Israel C; Sinha AM; Drexler H;
Eur J Heart Fail; 2011 Jul; 13(7):796-804. PubMed ID: 21555324
[TBL] [Abstract][Full Text] [Related]
2. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: the CONNECT-OptiVol study.
Zabel M; Vollmann D; Lüthje L; Seegers J; Sohns C; Zenker D; Hasenfuss G
Contemp Clin Trials; 2013 Jan; 34(1):109-16. PubMed ID: 23073567
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
[TBL] [Abstract][Full Text] [Related]
4. Remote monitoring: Doomed to let down or an attractive promise?
Lucà F; Cipolletta L; Di Fusco SA; Iorio A; Pozzi A; Rao CM; Ingianni N; Benvenuto M; Madeo A; Fiscella D; Benedetto D; Francese GM; Gelsomino S; Zecchin M; Gabrielli D; Gulizia MM
Int J Cardiol Heart Vasc; 2019 Sep; 24():100380. PubMed ID: 31193998
[TBL] [Abstract][Full Text] [Related]
5. Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients.
Vamos M; Nyolczas N; Bari Z; Bogyi P; Muk B; Szabo B; Ancsin B; Kiss RG; Duray GZ
Cardiol J; 2018; 25(2):236-244. PubMed ID: 28653309
[TBL] [Abstract][Full Text] [Related]
6. Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - .
Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Toyama Y; Yamada T; Doi M; Morita H; Ito H;
Circ J; 2015; 79(6):1315-22. PubMed ID: 25787230
[TBL] [Abstract][Full Text] [Related]
7. Intrathoracic impedance monitoring to predict decompensated heart failure.
Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
[TBL] [Abstract][Full Text] [Related]
8. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
[TBL] [Abstract][Full Text] [Related]
9. OptiVol for Volume Assessment in Patients With Continuous Flow Left Ventricular Assist Device.
Zeitler EP; Cooper LB; Clare RM; Chiswell K; Lowenstern A; Rogers JG; Milano CA; Schroder JN; Al-Khatib SM; Mentz RJ
ASAIO J; 2021 Feb; 67(2):192-195. PubMed ID: 33512914
[TBL] [Abstract][Full Text] [Related]
10. An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study.
Miyoshi A; Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Okawa K; Kawamoto K; Morita H; Ito H
J Cardiol; 2017 Nov; 70(5):425-431. PubMed ID: 28673507
[TBL] [Abstract][Full Text] [Related]
11. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).
Domenichini G; Rahneva T; Diab IG; Dhillon OS; Campbell NG; Finlay MC; Baker V; Hunter RJ; Earley MJ; Schilling RJ
Europace; 2016 Mar; 18(3):428-35. PubMed ID: 26683599
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices.
Lüthje L; Vollmann D; Seegers J; Sohns C; Hasenfuß G; Zabel M
Europace; 2015 Aug; 17(8):1276-81. PubMed ID: 25983310
[TBL] [Abstract][Full Text] [Related]
13. Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.
Zile MR; Sharma V; Johnson JW; Warman EN; Baicu CF; Bennett TD
Circ Heart Fail; 2016 Jan; 9(1):e002543. PubMed ID: 26699393
[TBL] [Abstract][Full Text] [Related]
14. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design.
Koehler F; Winkler S; Schieber M; Sechtem U; Stangl K; Böhm M; Boll H; Kim SS; Koehler K; Lücke S; Honold M; Heinze P; Schweizer T; Braecklein M; Kirwan BA; Gelbrich G; Anker SD;
Eur J Heart Fail; 2010 Dec; 12(12):1354-62. PubMed ID: 21098580
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an Integrated Device Diagnostics Algorithm to Risk Stratify Heart Failure Patients - Results From the SCAN-HF Study.
Okumura K; Sasaki S; Kusano K; Mine T; Fujii K; Iwasa A; Sunagawa O; Yamabe H; Takahashi N; Ishii S; Takeishi Y; Tsuboi N; Shizuta S; Aonuma K; Shimane A; Tada H; Ishikawa T; Tsunoda R; Numata T; Mukai Y; Kihara Y; Koehler J; Hidaka K; Sharma V
Circ J; 2020 Jun; 84(7):1118-1123. PubMed ID: 32448844
[TBL] [Abstract][Full Text] [Related]
16. Fundamentals of intrathoracic impedance monitoring in heart failure.
Wang L
Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
[TBL] [Abstract][Full Text] [Related]
17. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
Yamokoski LM; Haas GJ; Gans B; Abraham WT
Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
[TBL] [Abstract][Full Text] [Related]
18. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
Conraads VM; Spruit MA; Braunschweig F; Cowie MR; Tavazzi L; Borggrefe M; Hill MR; Jacobs S; Gerritse B; van Veldhuisen DJ
Circ Heart Fail; 2014 Mar; 7(2):279-87. PubMed ID: 24519908
[TBL] [Abstract][Full Text] [Related]
19. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
[TBL] [Abstract][Full Text] [Related]
20. Lifestyle Modification or Medication to Improve Condition of Patients With Asymptomatic Heart Failure - Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization II (MOMOTARO II) Study.
Miyoshi A; Nishii N; Okamoto Y; Fujita S; Kawamoto K; Okawa K; Hiramatsu S; Nakamura K; Morita H; Ito H
Circ J; 2020 Feb; 84(3):456-462. PubMed ID: 32037380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
